BSE filing, NSE: VENMAX. Summary written from the filing by ALFA Finder's alert engine.
Venmax Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹14.23
- Market cap
- ₹12.50 Cr
- Revenue (annual)
- ₹8.02 Cr
- Net profit (annual)
- ₹0.25 Cr
- P/E (TTM)
- 44.6×Sector 42.0×
- Promoter holding
- 10.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venmax Drugs & Pharmaceuticals Ltd
All →Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs' shareholders met on 24 October 2026 under an NCLT order to approve an amalgamation with Hatri Pharma. Voting results await the scrutinizer's report.
Venmax Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Venmax Drugs & Pharmaceuticals Annual General Meeting
Venmax Drugs and Pharmaceuticals held its 37th Annual General Meeting on September 26, 2026. Shareholders considered the financial statements and various directorship appointments.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.
Venmax Drugs & Pharmaceuticals Acquisition
NCLT Hyderabad directed Venmax to convene a shareholder meeting on 24 Oct 2026 for the amalgamation of Hatri Pharma into Venmax. The order also dispensed with meetings of Hatri Pharma's shareholders and creditors.
Venmax Drugs & Pharmaceuticals Annual Report
Venmax Drugs and Pharmaceuticals Limited has submitted its Annual Report for the Financial Year 2025-26, including the Notice for its 37th Annual General Meeting.
Other board meeting date announcements
All →Jindal Photo Board Meeting Date
Jindal Photo will hold a board meeting on November 13, 2026 to consider Q2FY27 and H1 unaudited results. The trading window stays closed until 48 hours after the results declaration.
Manappuram Finance Board Meeting Date
Manappuram Finance will hold a board meeting on November 12, 2026 to consider Q2FY27 and H1 results and an interim dividend. The trading window stays closed until November 16, 2026.
Titagarh Rail Systems Board Meeting Date
Titagarh Rail Systems will consider half-yearly results for September 2026 at a board meeting on 10 November. Trading window closes from 1 October until 13 November 2026.
NMS Global Board Meeting Date
NMS Global scheduled a board meeting for November 14, 2026 to consider unaudited standalone and consolidated half-yearly financial results. Trading window stays closed until November 16, 2026.
Emmforce Autotech Board Meeting Date
Emmforce Autotech scheduled a board meeting for November 11, 2026 to consider unaudited half-year results. The trading window stays closed until November 13, 2026.
Oneclick Logistics Board Meeting Date
Oneclick Logistics India will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated half-year results for September 2026. The trading window is closed from 1 October to 15 November 2026.